Actively Recruiting
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
Led by RAND · Updated on 2026-02-19
500
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
Sponsors
R
RAND
Lead Sponsor
A
Arrowhead Regional Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The ADAPT-ED study is a two-stage, sequential multiple assignment randomized trial (SMART) to inform the development of an adaptive intervention that is optimally effective in increasing long-term buprenorphine use for adults presenting to the ED with probable opioid use disorder (OUD).
CONDITIONS
Official Title
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presented for ED care at ARMC
- Age 18 or older
- Probable OUD diagnosis
- Speak and understand English or Spanish
- Have capacity to give informed consent
- Provide a signed and dated informed consent form
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Arrowhead Regional Medical Center
Colton, California, United States, 92324
Actively Recruiting
Research Team
M
Mariah Kalmin, PhD
CONTACT
P
P'trice Jones, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here